Naturally occurring variations of Polycomb repressive complex 1 (PRC1) comprise a core assembly of Polycomb group proteins and additional factors that include, surprisingly, autism susceptibility candidate 2 (AUTS2). Although AUTS2 is often disrupted in patients with neuronal disorders, the mechanism underlying the pathogenesis is unclear. We investigated the role of AUTS2 as part of a previously identified PRC1 complex (PRC1-AUTS2), and in the context of neurodevelopment. In contrast to the canonical role of PRC1 in gene repression, PRC1-AUTS2 activates transcription. Biochemical studies demonstrate that the CK2 component of PRC1-AUTS2 neutralizes PRC1 repressive activity, whereas AUTS2-mediated recruitment of P300 leads to gene activation. Chromatin immunoprecipitation followed by sequencing (ChIP-seq) demonstrated that AUTS2 regulates neuronal gene expression through promoter association. Conditional targeting of Auts2 in the mouse central nervous system (CNS) leads to various developmental defects. These findings reveal a natural means of subverting PRC1 activity, linking key epigenetic modulators with neuronal functions and diseases.
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Naturally occurring variations of Polycomb repressive complex 1 (PRC1) comprise a core assembly of Polycomb group proteins and additional factors that include, surprisingly, autism susceptibility candidate 2 (AUTS2). Although AUTS2 is often disrupted in patients with neuronal disorders, the mechanism underlying the pathogenesis is unclear. We investigated the role of AUTS2 as part of a previously identified PRC1 complex (PRC1-AUTS2), and in the context of neurodevelopment. In contrast to the canonical role of PRC1 in gene repression, PRC1-AUTS2 activates transcription. Biochemical studies demonstrate that the CK2 component of PRC1-AUTS2 neutralizes PRC1 repressive activity, whereas AUTS2-mediated recruitment of P300 leads to gene activation. Chromatin immunoprecipitation followed by sequencing (ChIP-seq) demonstrated that AUTS2 regulates neuronal gene expression through promoter association. Conditional targeting of Auts2 in the mouse central nervous system (CNS) leads to various developmental defects. These findings reveal a natural means of subverting PRC1 activity, linking key epigenetic modulators with neuronal functions and diseases.
Polycomb group (PcG) proteins maintain repressive forms of chromatin and therefore appropriate patterns of gene repression through epigenetic mechanisms. As such, PcG proteins have key roles in normal developmental progression, stem cell biology and cancer [1] [2] [3] [4] [5] [6] [7] [8] . The two major groups of PcG protein complexes exhibit distinct enzymatic activities: Polycomb repressive complex 2 (PRC2) catalyses di-and tri-methylation of histone H3 at lysine 27 (H3K27me2/3) [9] [10] [11] [12] , and Polycomb repressive complex 1 (PRC1) catalyses monoubiquitination of histone H2A at lysine 119 (H2AK119ub1) 13, 14 and/or compacts chromatin 15 . There are at least six distinct groups of mammalian PRC1 complexes, PRC1.1-1.6, each comprising one of six Polycomb group RING fingers (PCGFs) 16 , and the E3 ligase RING1A/B. Further diversification arises from the mutually exclusive association of RING1A/B with either RYBP or YAF2, or one of the CBX proteins [16] [17] [18] , which bind H3K27me3 through their chromodomains. Unlike their CBX-containing counterparts, RYBPcontaining PRC1 complexes adopt a PRC2/H3K27me3-independent mechanism for targeting chromatin 17 . Our previous studies revealed that PCGF3 and PCGF5 form novel PRC1 complexes which contain AUTS2 (ref. 16) . AUTS2 maps to chromosome 7q11.2, encodes a nuclear protein 19 , and is frequently reported as being disrupted in individuals suffering neurological disorders, including autism spectrum disorders (ASD) 20, 21 . Although recent studies implicate auts2 in regulating head size, neurodevelopment and enhancer function in zebrafish 22, 23 , the function of the AUTS2 protein has not been established nor has its role in regulating neuronal functions whose deregulation may result in pathogenesis.
The physical link between PRC1, a key epigenetic regulator, and AUTS2, a risk factor for ASD and other neurological disorders, prompted us to investigate the functional role of the AUTS2-containing PRC1 complex (PRC1-AUTS2). Here we report that PRC1-AUTS2 exhibits an unexpected role in transcriptional activation, in contrast to the repressive role of canonical PRC1. Furthermore, this conversion is mediated by AUTS2. Specific deletion of the Auts2 locus in mouse neuronal progenitor cells revealed a profound neurodevelopmental phenotype, in accordance with AUTS2 disruptions in humans.
An AUTS2-containing PRC1 complex
We pursued the unexpected association between PRC1 and AUTS2 (ref. 16 ) using tandem affinity purification (TAP), followed by mass spectrometry (MS) analysis with AUTS2 fused to sequential N-terminal Flag and HA tags (NFH). As previously reported 16 , NFH-AUTS2 was associated with PCGF3, and with components of PRC1.5, including PCGF5, RING1A/B, RYBP and its homologue YAF2, and casein kinase 2 (CK2) (Fig. 1a) . We focused on the AUTS2-containing PRC1.5 complex that we designated PRC1.5-AUTS2. Interestingly, several polypeptides that are not PRC1 components, including the co-activator P300, were also associated with AUTS2 (Fig. 1a) . Immunoprecipitation (IP) experiments performed with nuclear extract (NE) of 293 T-REx cells expressing a doxycycline-inducible NFH-AUTS2 and antibody against HA confirmed AUTS2 association with RING1B and PCGF5 (Fig. 1b) . Other PRC1 components not associated with PRC1.5, such as CBX2, PCGF4 (also known as BMI1), and PCGF1, comprising PRC1.2/4, PRC1.4, and PRC1.1, respectively, did not co-immunoprecipitate with AUTS2 (Fig. 1b) . Auts2 expression at the mRNA level was previously documented in mouse brain via in situ hybridization 19 . Indeed, RING1B, but not CBX2, interacts with AUTS2 in co-immunoprecipitation experiments performed using nuclear extract of embryonic day 15 (E15) mouse brain and AUTS2 antibody (Fig. 1c) , suggesting that PRC1.5-AUTS2 forms within the CNS.
AUTS2, PCGF5, RING1B, CK2B, and RYBP appear to form a stable complex as evidenced by glycerol gradient analysis of AUTS2-containing complexes (Fractions 9-11, Fig. 1d ). Although PCGF5 bound both RING1B and AUTS2 (Fig. 1e ), RING1B interacted with AUTS2 only in the presence of PCGF5 as evidenced by immunoprecipitations performed in vitro using insect-cell-expressed proteins (Fig. 1f) . PCGF5 is probably required to bridge RING1B and AUTS2 in complex formation. A similar in vitro immunoprecipitation experiment demonstrated that AUTS2 directly interacted with CK2 (Fig. 1g) . Thus, PRC1.5-AUTS2 contains at least five components: RYBP/YAF2, RING1A/B, PCGF5, AUTS2, and CK2 (Fig. 1h) . RING1A/B associates with PCGF5 as it does with other PCGFs 16 , and recruits RYBP/YAF2. AUTS2 is incorporated through its interaction with PCGF5. Moreover, AUTS2 recruits CK2 through direct interaction.
PRC1.5-AUTS2 activates transcription
Given that PRC1 functions as a transcriptional repressor through epigenetic mechanisms [1] [2] [3] 7 , we examined the effects of PRC1.5-AUTS2 on transcription and chromatin composition. We generated stable 293 T-REx cells containing an integrated luciferase reporter with five consecutive GAL4 DNA binding sites (UAS) (Fig. 2a) , and one of the following doxycycline-inducible candidates: GAL4-AUTS2, GAL4-RING1B, GAL4-PCGF4, GAL4-PCGF5 or GAL4 alone. Doxycycline treatment reduced luciferase activity in GAL4-PCGF4 cells, consistent with its role in transcriptional repression (Fig. 2b) . Surprisingly, doxycycline treatment increased luciferase activity in GAL4-PCGF5 or GAL4-AUTS2 cells ( Fig. 2b; Extended Data Fig. 1a ). This result was not due to a posttranscriptional event, as replacing the GAL4 DNA binding sequence with a Flag-HA tag (Flag-HA-AUTS2) resulted in the loss of AUTS2-associated transcriptional activation (Fig. 2b) . Interestingly, GAL4-RING1B gave rise to considerably weaker repression, compared to GAL4-PCGF4 (Fig. 2b) . Given that RING1A/B comprises all mammalian PRC1 complexes, the net outcome of GAL4-RING1B on transcription probably reflected the sum of all its associated complexes: repressive ones comprising PCGF4, and active ones comprising PCGF5 and AUTS2.
We next probed the luciferase reporter in GAL4-AUTS2 cells for the presence of PRC1.5-AUTS2 components, as well as indicators of chromatin structure, using ChIP followed by quantitative real-time polymerase chain reaction (qPCR). Upon doxycycline induction, GAL4-AUTS2 was recruited to the promoter region of the integrated luciferase locus (Fig. 2c) . As expected, RING1B and CK2B were also recruited (Fig. 2c) . Consistent with the locus being transcriptionally active (Fig. 2b) , Pol II was recruited, accompanied by an increase in trimethylation of histone H3 at lysine 4 (H3K4me3) which correlates with active transcription, and a reduction in H3K27me3 which correlates with repression, without appreciable change in total histone H3 (Fig. 2c) . Similar results were obtained using the GAL4-PCGF5 stable line, showing enrichment of Pol II and acetylation of histone H4 at lysine 16 (H4K16ac), an active histone modification, and reduction in H3K27me3 (Fig. 2d) . In addition to AUTS2, GAL4-PCGF5 recruited RING1B and CK2B (Fig. 2d) . PCGF5   AUTS2  RING1A  RING1B  RYBP  YAF2  CK2A1  CK2A2  CK2B  WDR68  FBRS  FBRSL1  PCGF3  P300  RERE  RBM14  ZNF608  ZNF609  TLE3  WDR5 ) induction. In this and subsequent luciferase reporter assays, each value is the mean of three independent measurements with error bars representing the standard error. *P , 0.05 by two-sided t-test, compared with the GAL4 control. c, d, ChIP using the antibodies indicated and GAL4-AUTS2 and GAL4-PCGF5 cells, respectively, before and after doxycycline induction. ChIP enrichment is expressed as percentage of input. All centre values represent the average of three technical replicates with error bars indicating standard deviation in this and all other ChIP experiments in this paper.
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To determine whether reporter gene activation required other components of the PRC1.5-AUTS2 complex, we silenced RING1B or PCGF5 through short interfering RNAs (siRNAs) in GAL4-AUTS2 cells. Indeed, relative to control siRNA treatment, luciferase activity driven by GAL4-AUTS2 was reduced (Extended Data Fig. 1b, c) . Similarly, AUTS2 knockdown in GAL4-PCGF5 cells led to decreased luciferase activity (Extended Data Fig. 1d , e). Thus, PRC1.5-AUTS2 creates a chromatin environment favourable to transcription dependent upon the integrity of the complex.
Mechanism of transcriptional activation
PRC1 can monoubiquitinate H2AK119 through its RING1B component. Addition of the PRC1.5-AUTS2 component, CK2, to the recombinant ternary complex RING1B-PCGF5-AUTS2 (Extended Data Fig. 2a ), compromised its ability to monoubiquitinate H2AK119 (Fig. 3a) . To rule out the possibility that CK2 may diminish the requisite ATP levels, E1 was pre-charged with ubiquitin and then quenched by EDTA (Extended Data Fig. 2b ). Inhibition of H2A monoubiquitination was still evident upon CK2 addition (Extended Data Fig. 2c ). Heat inactivation of CK2 obliterated its inhibitory effect (Fig. 3b) , indicating that its kinase activity may be required. Indeed, a kinase assay performed with CK2 and components used in the H2A monoubiquitination assay in the presence of [c- 32 P]ATP demonstrated that CK2 phosphorylated both RING1B and UbcH5c (Extended Data Fig. 2d ). An additional radiolabelled species was detectable, dependent upon the presence of nucleosomes, suggesting that CK2 may target one of the core histones under these conditions. Mass spectrometry analysis revealed that CK2 phosphorylated serines 41 (S41) and 168 (S168) of RING1B (Supplementary Table 1 ). RING1B substitution mutants were generated, containing either aspartic acid (RING1B-SD) or glutamic acid (RING1B-SE) to mimic phosphorylation at S41 and S168, respectively, or alanine (RING1B-SA) to mimic nonphosphorylated forms. Compared to the appropriate alanine substitution, RING1B(S168E) was substantially weaker in H2A monoubiquitination activity, (Fig. 3c, d ), whereas RING1B(S41D) showed no obvious difference (Extended Data Fig. 2e ). Thus, CK2 inhibits PRC1.5-AUTS2 monoubiquitination of H2AK119 through phosphorylation of RING1B at S168.
Although the presence of CK2 in PRC1.5-AUTS2 suppresses its H2A monoubiquitination activity, robust transcriptional activation probably entails an additional mechanism(s). Of note, the co-activator P300 that facilitates active transcription can associate with AUTS2 in a PRC1-independent manner (Fig. 1a) . Co-immunoprecipitation experiments in 293T cells confirmed that AUTS2 and P300 interact and in vitro pulldown experiments using recombinant AUTS2 and P300 demonstrated their direct interaction (Extended Data Fig. 3 ). Importantly, P300 was recruited to the promoter of the luciferase reporter upon GAL4-AUTS2 induction, as evidenced by ChIP results (Fig. 4a) . Moreover, siRNAmediated silencing of P300 (Fig. 4b, insert) led to a dramatic loss in GAL4-AUTS2-mediated activation of the luciferase reporter ( Fig. 4b ; Extended Data Fig. 4a) . A similar loss of activation was obtained upon treating the cells with the C646 inhibitor that specifically blocks P300 acetyltransferase activity ( Fig. 4c; Extended Data Fig. 4b ). On the basis of results using GAL4 fusions with truncated versions of AUTS2 in vivo, AUTS2 amino acids 404 to 913 (GAL4-AUTS2M) was sufficient to mediate transcriptional activation (Fig. 4d) . Interestingly, this region overlaps a C-terminal portion of AUTS2 that correlates with severe human phenotypes 22 . ChIP analysis revealed that truncated versions of . a, In vitro nucleosomal H2A monoubquitination assay using RING1B-PCGF5-AUTS2 expressed in and purified from Sf9 cells (Methods), as a function of the presence of recombinant CK2. Reaction products were resolved on SDS-PAGE, followed by immunoblotting for H2AK119ub1. Ponceau staining of histones is shown (bottom). b, Effect of heat-treatment of CK2 at 95 uC for 15 min before addition to the H2A monoubquitination assay performed as in a. c, H2A monoubquitination assay (Methods) using increasing amounts of RING1B-PCGF5-AUTS2 containing either RING1B(S168A) (S168 to alanine), or RING1B(S168E) (S168 to glutamic acid), purified from Sf9 cells. d, Densitometry of H2A monoubquitination based on three independent experiments as in c. Quantification was done by using ImageJ software. Error bars represent standard deviation. GAL4-AUTS2 activate transcription dependent upon the ability to recruit P300 (Fig. 4e) . Thus, through its recruitment of CK2 and interaction with P300, AUTS2 is the key to converting repressive PRC1 to a transcriptional activator.
AUTS2 regulates CNS gene expression
The tissue distribution of AUTS2 during development was assessed using immunohistochemistry (IHC) and validated AUTS2 antibody (Extended Data Fig. 5a ). AUTS2 is highly expressed in the CNS of E15 mouse embryo, with the highest level being apparent in the neocortex (Extended Data Fig. 5b ). AUTS2 was detected in postnatal day 30 (P30) adult mouse brain sections, especially in hippocampus, cerebral cortex, and Purkinje cells in the cerebellum, but at considerably lower levels (Extended Data Fig. 5c ). Western blot analyses confirmed AUTS2 expression in the brain as a function of development (Extended Data Fig. 5d ), consistent with reported Auts2 mRNA levels 19 . Furthermore, AUTS2 is probably expressed primarily in neurons based on immunofluorescence analysis (Extended Data Fig. 5e ) and prior studies 19 . We next performed ChIP followed by deep sequencing (ChIP-seq) to determine the genomic localization of AUTS2 and RING1B, and the co-presence of various histone modifications and Pol II using P1 mouse brain. AUTS2 was found predominantly in the 6 5 kb region surrounding transcriptional start sites (TSS) (Extended Data Fig. 6a, b) . Several promoters were co-bound by AUTS2, Pol II, and histone modifications associated with active transcription, including histone H3 acetylated at lysine 27 (H3K27ac), and H3K4me3 (Fig. 5a) . Moreover, the gene bodies following these promoters were decorated with trimethylation of histone H3 at lysine 36 (H3K36me3), a modification linked with Pol II elongation (Fig. 5a ). H3K27me3 was not detected at these AUTS2 bound promoters (Fig. 5a) , consistent with the absence of detectable CBX protein in PRC1.5-AUTS2. Importantly, although RING1B was enriched at these promoters, its enzymatic product H2AK119ub1 was absent (Fig. 5a) .
We then performed genome-wide analysis and identified significantly enriched peaks, as reported previously 16 . Approximately 50% of AUTS2-containing peaks comprise regions bound by H3K27ac, whereas only 9.0% were bound by H2AK119ub1 (Fig. 5b) , consistent with the intrinsic E3 ligase activity of RING1A/B being suppressed in PRC1.5-AUTS2, as shown in vitro (Fig. 3a) . Amongst the AUTS2 target genes identified, ,35.2% comprise the top 25% highly transcribed genes in mouse brain based on reads per kilobase of exon per million reads mapped (RPKM) values obtained from our RNA-seq analysis in P1 mouse whole brain (Extended Data Fig. 6c ). In contrast, only 8.9% comprise the bottom 25% genes with the lowest RPKM values (Extended Data Fig. 6c) . We next identified genes co-targeted by AUTS2 and RING1B, and those by BMI1 and RING1B as control. Out of 4,168 AUTS2 target genes, 1,488 were also bound by RING1B; whereas out of 1,919 BMI1 target genes, 1,137 were also bound by RING1B. The average expression of AUTS2 or AUTS2/ RING1B target genes was significantly higher than those of BMI1 or BMI1/RING1B (Fig. 5c) . Of note, the overlap between AUTS2-and RING1B-targeted genes is relatively low, indicating that AUTS2 may be recruited to chromatin through PRC1-independent mechanism(s), perhaps involving other AUTS2 interacting candidates identified by our TAP analysis (Fig. 1a) .
AUTS2/RING1B co-targeted loci comprised higher levels of H3K27ac and Pol II, and lower levels of H2AK119ub1 and H3K27me3, relative to BMI1/RING1B co-targets (Fig. 5d) . Moreover, P300 was localized to AUTS2-targeted loci and its global occupancy was higher on loci targeted by AUTS2/RING1B than those by BMI1/RING1B, as evidenced by ChIP-seq in mouse brain (Extended Data Fig. 7 ). Gene Ontology (GO) analysis of AUTS2 targets in mouse brain revealed enrichment of functional terms including ''gene expression'', ''abnormality of the forebrain'', and ''abnormality of the cerebrum'' ( Fig. 5e; Supplementary Table 2) , indicating a role of AUTS2 in positively regulating the CNS transcriptional program.
RING1B was similarly associated with AUTS2 target genes in 293 T-REx cells, as shown by ChIP-seq (Extended Data Fig. 8) . A substantial portion of HA-AUTS2 peaks (approximately 30%: 1,664 out of 5,563 peaks) were also bound by HA-RING1B (Extended Data Fig. 8c ). -2,000 -1,000 0 1,000 2,000 -2,000 -1,000 0 1,000 2,000 -2,000 -1,000 0 1,000 2,000 -2,000 -1,000 0 1,000 2,000 RPKM values are obtained from our RNA-seq data in mouse whole brain. d, ChIP reads density plots for levels of indicated histone marks and Pol II at loci co-targeted by AUTS2/RING1B and BMI1/RING1B. A 6 2 kb window relative to the centre of peaks is shown. e, GO analysis of targeted genomic regions identified by AUTS2 ChIP-seq. The x axis (in logarithmic scale) corresponds to the binomial raw P values.
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NFH-AUTS2 induction in 293 T-REx cells had no effect on RING1B and RYBP mRNA levels as assessed by reverse transcription qPCR (RT-qPCR), whereas mRNA levels of several genes among the top 20 HA-AUTS2 targets were generally increased (Extended Data Fig. 8f) , consistent with PRC1.5-AUTS2 mediating transcriptional activation.
Phenotypes in Auts2 KO mice
AUTS2 function in the brain was assessed using Auts2 conditional knockout (cKO) mice generated by crossing mice harbouring LoxP sites flanking exon 7 of Auts2 with mice carrying nestin promoter-driven Cre recombinase ( Fig. 6a; Extended Data Fig. 9a, b) . Although AUTS2 disruptions normally occur on one of the two alleles in patients, we characterized full homozygous knockout (KO) as well as heterozygous knockout of Auts2 (Het) to better understand the Auts2 phenotype, as well as understand gene dosage effects. In humans, ,80% of all AUTS2 disruptions are associated with either low birth weight or small stature 21 . Consistent with this observation, we observed both a striking visual (Fig. 6a) and quantitative (Fig. 6b; Extended Data Fig. 9c) 21 . We explored such developmental milestones in mice as a function of Auts2 disruption using a pre-weanling behavioural test battery including basic motor skills (for example, righting reflex) and ultrasonic vocalizations (USVs) following maternal separation, often impaired in a variety of mouse models of neurodevelopmental disorders [24] [25] [26] . Across early development, knockout mice were deficient in both righting reflex and ultrasonic vocalizations emitted (Fig. 6c, d) , as well as in negative geotaxis (Extended Data Fig. 9d ). Although the knockouts showed a significantly smaller milk band at P1, early malnutrition or abnormal maternal behaviour may not be fully responsible for all of the observed phenotypes, given that the heterozygoes showed phenotypes similar to the knockout although having a milk band indistinguishable from wild type (Extended Data Fig. 9e) . Although it is difficult to directly infer human pathology from mouse phenotypes, these results strongly suggest that a gene dosage-dependent disruption of mouse Auts2 resulted in impaired developmental phenotypes characteristic of AUTS2 disruption in humans.
Several selected genes co-targeted by AUTS2 and RING1B exhibited decreased mRNA levels in the knockout relative to wild-type mouse whole brains as evidenced by RT-qPCR (Extended Data Fig. 10 ). In particular, disruption of Nat8l has been associated with many of the phenotypes observed in AUTS2 patients (for example, growth delay, intellectual disability) [27] [28] [29] , suggesting that Auts2 disruption in these mice may lead to developmental defects through altered expression of its target genes.
Discussion
Active promoters have been linked previously with the presence of PRC2 or PRC1 (refs 30-33 ), yet the heterogeneous compositions of these complexes hampered further investigations. Here we identified AUTS2 as the component that renders PRC1 capable of transcription stimulation, through AUTS2-mediated recruitment of CK2 and P300 (Fig. 6e) . These findings underscore that natural variation in the constituents of PRC1 complexes can lead to PRC1 adopting unexpected roles in coordinating specific cellular gene expression profiles. Our findings may set a precedent for other dynamic alterations in the regulatory properties of PRC1 and perhaps PRC2, based on their constituent components.
Despite much evidence from human genetics indicating that AUTS2 disruption is associated with neurological disorders including ASD, AUTS2 function was unclear 21 . Our results provide the first, to our knowledge, causal evidence for Auts2 disruption leading to specific behavioural phenotypes associated with the human condition. Although the precise neurobiological mechanisms underlying these developmental phenotypes are yet to be elucidated, AUTS2 association with active transcription and H3K4me3 point to its having a key role in regulating early transcriptional programs associated with normal brain development 34, 35 . AUTS2 is highly enriched in the prefrontal cortex (PFC) and recent evidence suggests that the genome-wide distribution of H3K4me3 peaks fail to exhibit the normal developmental shift at a number of genes implicated in ASD pathology (for example, PARK2, NLGN4Y, SHANK3), in the PFC of ASD patients 35 . Furthermore, recent evidence provide a strong case for aberrant epigenetic regulation in the cerebellum of ASD patients 36, 37 . These findings combined with the enrichment of AUTS2 , and { (between heterozygote and knockout). Total numbers of mice used in the behavioural analyses are as following (the range reflects different numbers used for each behavioural test): at P3, wild type n 5 11-17, heterozygote n 5 3-10, knockout n 5 6-11; at P5, wild type n 5 23-27, heterozygote n 5 8-13, knockout n 5 18-19; at P7, wild type n 5 7-11, heterozygote n 5 3, knockout n 5 8; at P9, wild type n 5 4-8, heterozygote n 5 2-7, knockout n 5 3. Analysis was performed in at least three different litters of pups for each behavioural test. c, Knockout mice show impairment in righting reflex relative to wild type from P3-P9, whereas heterozygotes are not impaired. d, Both heterozygote and knockout mice show significantly less ultrasonic vocalizations (USVs) than wild type following maternal separation across the majority of developmental time points measured. e, A model for PRC1.5-AUTS2-mediated transcriptional activation.
See main text for details.
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in cerebellar Purkinje cells and the PFC suggest that these brain regions may be involved in conferring the Auts2 phenotype 26 . The novel role of AUTS2 in modulating PRC1 activity to effectively remove its repressive function and exploit the complex to attain activated transcription will probably encourage alternate directions in addressing the challenges of ASD and related neurological diseases.
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METHODS
Plasmids. For construction of pINTO-NFH-AUTS2, cDNA for human AUTS2 was purchased from ATCC and cloned into the vector pINTO-NFH carrying N-terminal Flag and HA tags, as described previously 16 . For pINTO-GAL4-AUTS2, the same cDNA was cloned into pINTO-GAL4 with a GAL4 DNA binding sequence replacing the N-terminal Flag and HA tags. For truncated GAL4-AUTS2, PCR was used to amplify the fragments of interest before inversion to the pINTO-GAL4 vector. For RING1B, PCGF4, and PCGF5, cDNA obtained from digestion of pINTO-NFH-RING1B, pINTO-NFH-PCGF4, and pINTO-NFH-PCGF5, respectively, were cloned into pINTO-GAL4. For protein expression in insect cells, cDNAs of interest were cloned into pFastbac vectors. Cell culture. Stable cells expressing pINTO-NFH-AUTS2 were generated from human 293 T-REx cells and maintained as described previously 16 . For those expressing GAL4-fusion proteins, vector control (pINTO-GAL4) or constructs made in this vector were tranfected into 293 T-REx-luciferase cells containing a stable integrated 5XGal4RE-tk-Luc-neo construct 38 , and selected with 200 mg ml 21 zeocin, 10 mg ml 21 blasticidin, and 400 mg ml 21 G418. RNA interference. Cells were transfected with siRNAs using Lipofectamine RNAiMAX (Life Technologies) according to the manufacturer's protocol. All human siRNAs were purchased: si-ctrl (AllStars Negative Control siRNA, cat no. SI03650318) and si-RING1B (cat no. SI00095543, target sequence: 59-TGGGCTAGAGCTTG ATAATAA-39) were from Qiagen; si-P300 (cat no. 4392420, ID no. s4695, target sequence: 59-GGACTACCCTATCAAGTAA-39) was from Ambion; si-PCGF5 (cat no. L-007089-00-0005, target sequences: 59-CAACAACAGTGACGGAATG-39, 59-GAGGTTGGACA ATACATTA-39, 59-ACAAATTGCTATCTGTCTA-39, 59-G AAGAAATTCATTCGATGT-39) and si-AUTS2 (cat# L-013932-00-0005, target sequences: 59-TGACAGAGATAGAGATGTA-39, 59-AGACTCATCTGTTAGT AAA-39, 59-GAAAGGCTCAGTGATAGTT-39, 59-CACATAA GCTGGACTTT GG-39) were from Thermo Scientific. Affinity purification, protein identification, and glycerol gradient. To identify proteins associated with AUTS2, tandem affinity purification was performed in nuclear extract (NE) of 293 T-REx cells expressing NFH-AUTS2, as described previously 16 . Briefly, nuclear extract prepared from 30 3 150 mm plates of cells was incubated with Flag M2 beads at 4 uC overnight. After 5 washes, proteins bound on the M2 beads were eluted with 500 ml Flag peptides at 250 mg ml 21 at 4 uC for 1 h. The M2 eluate was then incubated with 30 ml HA beads at 4 uC for 4 h. The HA beads were washed 5 times and proteins eluted with 100 ml glycine (0.1 M, pH 2.0), and then neutralized by adding 6.5 ml Tris solution (1.5 M, pH 8.8), resulting in the final HA eluate, which was then analysed by LC-MS.
For glycerol gradient analysis, 100 ml M2 eluate was subjected to ultracentrifugation followed by fractionation, as described previously 16 . The odd-numbered fractions were then subjected to western blotting. Immunoprecipitation and in vitro interaction assay. Immunoprecipitation experiments were performed as described previously 16 with certain modifications. For immunoprecipitation, nuclear extract prepared from the indicated sources was incubated with antibodies before addition of protein G beads, or with Flag or HA beads at 4 uC for 3 h. For in vitro interaction assay, 60 h after infection with baculovirus for proteins of interest, Sf9 cells were harvested lysed in lysis buffer (20 mM TrisHCl, pH 8.0, 500 mM NaCl, 4 mM MgCl 2 , 0.4 mM EDTA, 2 mM DTT, 20 mM bglycerophosphate, 20% glycerol, 0.4 mM PMSF, 1 mg ml 21 pepstatin A, 1 mg ml 21 leupeptin, 1 mg ml 21 aprotinin), followed by centrifugation. Lysate containing the indicated proteins were incubated with Flag or HA beads at 4 uC for 3 h. Beads were then washed 5 times and eluted with 100 ml glycine (0.1 M, pH 2.0), and then neutralized by adding 6.5 ml Tris solution (1.5 M, pH 8.8). The eluted samples were mixed with SDS sample buffer and analysed by SDS-PAGE, followed by immunoblotting. Luciferase reporter assay. 293T-REx-luciferase cells 38 stably transfected with pINTO-GAL4 vector control or with inserts of interest were treated with 100 ng ml 21 doxycycline. Cells were lysed by adding 250 ml of ice-cold lysis buffer (0.2% Triton X-100, 100 mM potassium phosphate, pH 7.8, and 1 mM DTT) and shaking for 10 min at 4 uC. The cell lysate was centrifuged at 20,000g for 10 min and the protein concentration of the resulting supernatant was determined by Bradford assay. 30 mg of the supernatant was assayed for luciferase activity using luciferase assay substrate (Promega). Purification of crosslinked nuclei from whole mouse brains. Nuclei from whole mouse brains were purified as previously described for cerebellar mouse nuclei 39 including minor changes. Briefly, CD1 pups at P1 were isolated from the embryonic sac and their whole brains quickly dissected. The whole brains were homogenized with a glass douncing homogenizer using first a loose, then tight pestle (Kimble Chase; 1984-10002). The cell homogenate was fixed with a final concentration of 1% paraformaldehyde for 8 min at room temperature and the reaction quenched with 0.125 M glycine for 5 min at room temperature. To isolate the nuclei, the fixed homogenate was spun through a 29% iodixanol cushion and the nuclei pellet resuspended in resuspension buffer (0.25 M sucrose, 25 mM KCl, 5 mM MgCl 2 , 20 mM tricine, pH 7.8 and 10% donkey serum) supplemented with 0.15 mM spermine, 0.5 mM spermidine and EDTA-free protease inhibitor cocktail (Roche; 11836170001). Resuspended nuclei were counted using a hemocytometer and aliquots of 10 8 nuclei pelleted by centrifugation at 2,000g for 15 min at 4 uC. Nuclei pellets were flash-frozen in liquid nitrogen and stored at 280uC until further analysis. ChIP and ChIP-seq. Chromatin IP (ChIP) was performed as described previously 16 . Briefly, crosslinked and isolated nuclei were sonicated using a Diagenode Bioruptor to an average size of ,250 bp. After pre-clearing with BSA-blocked protein G Sepharose, chromatin was incubated with antibodies at 4 uC overnight. The chromatin immunocomplexes were recovered with the same BSA-blocked protein G beads. For ChIP-seq library construction, 5-10 ng of DNA extracted from the chromatin immunocomplexes as described previously 15 . Libraries were prepared according to manufacturer's instructions (Illumina) and as described 15 . Immunoprecipitated DNA was first end-repaired using End-It Repair Kit (Epicentre), tailed with an A using Klenow exo minus (NEB M0212), and ligated to custom adapters with LigaFast (Promega, no. M8225). Fragments of 350 6 50 bp were size-selected and subjected to ligation-mediated PCR amplification (LM-PCR), using Phusion DNA polymerase (NEB M0530). Libraries were quantified with quantitative PCR using primers annealing to the adaptor sequence and sequenced at a concentration of 7 pM on an Illumina HiSeq 2000. All sequencing data has been deposited into GEO/NCBI with the accession number GSE60411. ChIP-seq Analysis. ChIP-seq analysis was performed as described previously 16 with certain modifications. Sequenced reads (36 bp) were aligned to the mouse reference genome (assembly mm9) for each ChIP-seq experiment in mouse brain, and to human reference genome (assembly hg19) for each ChIP-seq experiment in 293T-REx cells using Bowtie 40 . Duplicated reads were removed with samtools 41 . ChIP-seq read density files were generated using igvtools and were viewed in Integrative Genomics Viewer (IGV) 42 . Significantly (P , 0.01) enriched peaks for each ChIP-seq data set were identified with QESEQ 43 and ranked according to the total number of reads mapping to them. Venn diagram of overlap among peaks ( Fig. 5b ; Extended Data Fig. 8c-e) was computed using the R statistical software package (http://cran.r-project.org). Correlation of AUTS2 target genes with their expression level (Extended Data Fig. 6c ) was obtained by intersecting with a gene list ranked by RPKM values obtained by our RNA-seq study in P1 mouse brain. The same RPKM values were used to produce the box-and-whisker plot (Fig. 5c) . ChIP reads density plots (Fig. 5d) were made using HOMER by calculating average tag densities across 6 2 kb regions surrounding indicated peaks. Gene associated region annotations (Fig. 5e) were obtained with genomic regions enrichment of annotations tool (GREAT) 44 . Genomic distribution of peaks relative to TSS (Extended Data Figs 6b, 8b) was obtained via HOMER. In vitro H2A ubiquitination assays. Assays were performed as described previously 16 with certain modifications. Briefly, in the presence of 100 nM E1 (Boston Biochem), 500 nM UbcH5c (Boston Biochem), 10 mM HA-ubiquitin (Boston Biochem), 0.5 mM ATP, 0.1 mg ml 21 creatine kinase, 25 mM phosphocreatine, 1 mg ml 21 BSA, and 2 ml of 103 ubiquitination reaction buffer (500 mM Tris-HCl, pH 7.5, 50 mM MgCl 2 , 10 mM DTT), reactions were assembled with reconstituted oligonucleosomes (,2.5 mg) and purified complexes or proteins in a total volume of 20 ml. After 1 h incubation at 37 uC, the reactions were stopped by boiling in SDS sample buffer, and then resolved on SDS-PAGE, followed by immunoblotting. To test the effect of CK2 (NEB, P6010) on ubiquitination (Figs 3a and b) , recombinant RING1B-PCGF5-AUTS2 complex purified from Sf9 cells was incubated with CK2 in reaction buffer (20 mM Tris-HCl, pH 7.5, 50 mM KCl, and 10 mM MgCl 2 ) in the presence of ATP, creatine kinase, phosphocreatine, and BSA at 4 uC for overnight to minimize the inactivation of CK2. Other components were then added and incubated for additional 1 h at 37 uC. For the experiment with E1 pre-charged with ubiquitin (Extended Data Fig. 2c ), 5-fold E1 was incubated with HA-ub and ATP at room temperature for 30 min and then quenched with 20 mM EDTA at room temperature for 10 min. All the other components except for nucleosomes were incubated at 4 uC for overnight and also quenched by EDTA. These two mixtures were then mixed and supplemented with nuclesomes and incubated at 37 uC for another 30 min. In vitro CK2 kinase assays. The reactions were assembled with components used in the in vitro H2A ubiquitination assays at the same concentrations, with the exception of 50 mM in the case of ATP. CK2 was then added at 300 nM along with 2 mCi [c- 32 P]ATP (PerkinElmer, BLU502H500UC), followed by incubation at 37 uC for 30 min. The reactions were then resolved on SDS-PAGE and visualized by radiograph. For identification of phosphorylation sites on CK2 substrates, [c- 32 P]ATP was omitted in the assays. After SDS-PAGE and Coomassie blue staining, bands corresponding to specific proteins were excised and sent for mass spectrometry analysis. Mice. Mice harbouring LoxP sites flanking Auts2 exon 7 were generated at the Janelia Farms Gene Targeting and Transgenics Resource Center and were backcrossed onto the C57Bl/6J strain. Nervous system-specific deletions of Auts2 was performed by crossing to nestin promoter driven Cre mice purchased from the ARTICLE RESEARCH Extended Data Figure 1 | Requirement of the integrity of the PRC1-AUTS2 complex for transcriptional activation. a, Luciferase activity in screened stable cell clones expressing GAL4-PCGF5, 24 h after induction by doxycycline at 100 mg ml 21 . b, Fold change in luciferase activity in GAL4-AUTS2 cells upon knockdown of RING1B or PCGF5. Cells were transfected with Lipofectamine 2000 RNAiMAX and siRNAs against RING1B or PCGF5, or control siRNAs for two days and then 100 mg ml 21 doxycycline was added to induce GAL4-AUTS2 expression. Then 24 h after induction, luciferase activity was measured. Each value is the mean of three independent measurements. Error bars represent standard error. c, Immunoblotting of samples used for luciferase activity reporter assay as in b using the antibodies indicated. d, Fold change in luciferase activity in GAL4-PCGF5 cells upon knockdown of AUTS2. Cells were treated as in b. e, Immunoblotting of samples used for luciferase activity reporter assay as in d using the antibodies indicated.
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